

(Sharecast News) - Antibodies developer Bioventix named Bruce Hiscock would join the group its new chief financial officer on Wednesday.


CORRECT: Bioventix Reports "Strong" Interims, Increases Dividend


Bioventix Reports "Strong" Interim Performance, Increases Dividend


DIRECTOR DEALINGS: Bioventix Non-Exec Chair Sells GBP78,000 In Shares


(Sharecast News) - Bioventix, which specialises in the development and commercial supply of high-affinity monoclonal antibodies for applications in cl...


(Sharecast News) - Monoclonal antibodies developer and supplier Bioventix reported a 24% improvement in its normalised revenue in its half-year report...


(Sharecast News) - Aim's Bioventix announced Monday it would pay a special dividend after a strong year of revenue and profit growth - but also sounde...


LONDON (Alliance News) - Medical technology company Bioventix PLC on Monday said it saw an increase in revenue and profit in the first half of its fin...